Evaluation of Dermatology Consultations Requested from the Pediatric Clinic

Autor: Cüneyt Uğur, Cahit Yavuz

Publikováno v: Genel Tıp Dergisi, Vol 32, Iss 1, Pp 68-71 (2022)

Objective: The aim of this study is to evaluate the clinical, demographic, and diagnostic characteristics of pediatric patients consulting the dermatology department. Methods: Patients who were consulted to the dermatology department from pediatric c

Externí odkaz: https://doaj.org/article/77fbfb638a7c494d9c21042ebb2079f4

Herpes Zoster enfeksiyonu sırasında laboratuvar parametrelerinin karşılaştırılması: bir olgu kontrol çalışması

Autor: Güder H., Demir Ş., Guder S.

Publikováno v: Turkiye Klinikleri Journal of Dermatology. 33:21-29

Objective: We aimed to find the parameters that can change during herpes zoster infection and observe the relationship of these parameters throughout the disease. Material and Methods: We compared 40 herpes zoster patients and 2 separate control grou

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::944e838413b935d1346925aaed8043a0
https://doi.org/10.5336/dermato.2022-91270

Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?

Autor: Emek Kocatürk, Emel Bülbül Başkan, Özlem Su Küçük, Mustafa Özdemir, Sinem Örnek, Pelin Kuteyla Can, Eda Haşal, Burhan Engin, Nilgün Atakan, Erkan Alpsoy

Publikováno v: Anais Brasileiros de Dermatologia
Anais Brasileiros de Dermatologia v.97 n.5 2022
Anais brasileiros de dermatologia
Sociedade Brasileira de Dermatologia (SBD)
instacron:SBD
Anais Brasileiros de Dermatologia, Volume: 97, Issue: 5, Pages: 592-600, Published: 30 SEP 2022

Background: chronic Spontaneous Urticaria (CSU) is characterized by recurrent wheals and/or angioedema for longer than 6-weeks. Guidelines recommend Omalizumab (Oma) as first-line and Cyclosporine-A (Cs-A) as second-line treatment in antihistamine re

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f7b05432a650a74525226e3dedec7f38
https://doi.org/10.1016/j.abd.2022.03.003

Evaluating the Scales Used To Diagnose Incontinence-Associated Dermatitis: A Systematic Review

Autor: Bilge, Tezcan, Canan, Eraydın, Bilgi Gülseven, Karabacak

Publikováno v: Advances in Skin & Wound Care. 35:1-9

OBJECTIVE: To investigate the scales used in the diagnosis of incontinenceassociated dermatitis (IAD), including the risk factors included in the scales, their reliability and validity, and in which patient groups the scales have been applied. DATA S

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6c019a4facf50c458f22e1bc792ef1c9
https://doi.org/10.1097/01.asw.0000823988.56640.72

Tildrakizumab for the treatment of exfoliative cheilitis

Autor: Timothy COWAN, Nada ABU ALRUB, Anna WİLSON, Mani MAKHİJA, Dedee MURRELL

Publikováno v: Volume: 6, Issue: 1 19-21
Mucosa

Exfoliative cheilitis is an inflammatory condition that can significantly impair quality of life. This is the first reported case of an interleukin-23 inhibitor, tildrakizumab, for the treatment of a chronic, refractory case of exfoliative cheilitis.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a54e32ee8b428bde7075531636f9e90e
https://doi.org/10.33204/mucosa.1209480